Literature DB >> 33446647

Probing the clinical and brain structural boundaries of bipolar and major depressive disorder.

Tao Yang1,2, Sophia Frangou2,3, Raymond W Lam2, Jia Huang1, Yousong Su1, Guoqing Zhao4, Ruizhi Mao1, Na Zhu5, Rubai Zhou1, Xiao Lin1, Weiping Xia6, Xing Wang1, Yun Wang1, Daihui Peng1, Zuowei Wang7, Lakshmi N Yatham2, Jun Chen8, Yiru Fang9,10,11.   

Abstract

Bipolar disorder (BD) and major depressive disorder (MDD) have both common and distinct clinical features, that pose both conceptual challenges in terms of their diagnostic boundaries and practical difficulties in optimizing treatment. Multivariate machine learning techniques offer new avenues for exploring these boundaries based on clinical neuroanatomical features. Brain structural data were obtained at 3 T from a sample of 90 patients with BD, 189 patients with MDD, and 162 healthy individuals. We applied sparse partial least squares discriminant analysis (s-PLS-DA) to identify clinical and brain structural features that may discriminate between the two clinical groups, and heterogeneity through discriminative analysis (HYDRA) to detect patient subgroups with reference to healthy individuals. Two clinical dimensions differentiated BD from MDD (area under the curve: 0.76, P < 0.001); one dimension emphasized disease severity as well as irritability, agitation, anxiety and flight of ideas and the other emphasized mostly elevated mood. Brain structural features could not distinguish between the two disorders. HYDRA classified patients in two clusters that differed in global and regional cortical thickness, the distribution proportion of BD and MDD and positive family history of psychiatric disorders. Clinical features remain the most reliable discriminant attributed of BD and MDD depression. The brain structural findings suggests that biological partitions of patients with mood disorders are likely to lead to the identification of subgroups, that transcend current diagnostic divisions into BD and MDD and are more likely to be aligned with underlying genetic variation. These results set the foundation for future studies to enhance our understanding of brain-behavior relationships in mood disorders.

Entities:  

Mesh:

Year:  2021        PMID: 33446647      PMCID: PMC7809029          DOI: 10.1038/s41398-020-01169-7

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  47 in total

1.  Validity and reliability of the Chinese version of the Sheehan Disability Scale (SDS-C).

Authors:  Shang-Herng Leu; Jen-Yu Chou; Pei-Chin Lee; Hsiu-Chu Cheng; Wen-Chuan Shao; Wan-Lin Hsien; Chieh-Liang Huang; Vincent Chin-Hung Chen
Journal:  Asia Pac Psychiatry       Date:  2015-04-02       Impact factor: 2.538

2.  A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; William Coryell; Jean Endicott; Jack D Maser; David A Solomon; Andrew C Leon; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2003-03

Review 3.  Will machine learning applied to neuroimaging in bipolar disorder help the clinician? A critical review and methodological suggestions.

Authors:  Laurie-Anne Claude; Josselin Houenou; Edouard Duchesnay; Pauline Favre
Journal:  Bipolar Disord       Date:  2020-03-20       Impact factor: 6.744

Review 4.  A comprehensive review and model of putative prodromal features of bipolar affective disorder.

Authors:  O D Howes; S Lim; G Theologos; A R Yung; G M Goodwin; P McGuire
Journal:  Psychol Med       Date:  2010-09-14       Impact factor: 7.723

5.  Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP).

Authors:  Takeshi Inoue; Yoshifumi Inagaki; Toshifumi Kimura; Osamu Shirakawa
Journal:  J Affect Disord       Date:  2014-12-15       Impact factor: 4.839

Review 6.  Phenomenology and treatment of agitation.

Authors:  A F Schatzberg; C DeBattista
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

Review 7.  Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives.

Authors:  Jorge Renner Cardoso de Almeida; Mary Louise Phillips
Journal:  Biol Psychiatry       Date:  2012-07-10       Impact factor: 13.382

Review 8.  Differentiating between bipolar and unipolar depression in functional and structural MRI studies.

Authors:  Kyu-Man Han; Domenico De Berardis; Michele Fornaro; Yong-Ku Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-03-28       Impact factor: 5.067

9.  Interactive impact of childhood maltreatment, depression, and age on cortical brain structure: mega-analytic findings from a large multi-site cohort.

Authors:  Leonardo Tozzi; Lisa Garczarek; Deborah Janowitz; Dan J Stein; Katharina Wittfeld; Henrik Dobrowolny; Jim Lagopoulos; Sean N Hatton; Ian B Hickie; Angela Carballedo; Samantha J Brooks; Daniella Vuletic; Anne Uhlmann; Ilya M Veer; Henrik Walter; Robin Bülow; Henry Völzke; Johanna Klinger-König; Knut Schnell; Dieter Schoepf; Dominik Grotegerd; Nils Opel; Udo Dannlowski; Harald Kugel; Elisabeth Schramm; Carsten Konrad; Tilo Kircher; Dilara Jüksel; Igor Nenadić; Axel Krug; Tim Hahn; Olaf Steinsträter; Ronny Redlich; Dario Zaremba; Bartosz Zurowski; Cynthia H Y Fu; Danai Dima; James Cole; Hans J Grabe; Colm G Connolly; Tony T Yang; Tiffany C Ho; Kaja Z LeWinn; Meng Li; Nynke A Groenewold; Lauren E Salminen; Martin Walter; Alan N Simmons; Theo G M van Erp; Neda Jahanshad; Bernhard T Baune; Nic J A van der Wee; Marie-Jose van Tol; Brenda W J H Penninx; Derrek P Hibar; Paul M Thompson; Dick J Veltman; Lianne Schmaal; Thomas Frodl
Journal:  Psychol Med       Date:  2019-05-14       Impact factor: 10.592

10.  Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.

Authors:  L Schmaal; D P Hibar; P G Sämann; G B Hall; B T Baune; N Jahanshad; J W Cheung; T G M van Erp; D Bos; M A Ikram; M W Vernooij; W J Niessen; H Tiemeier; A Hofman; K Wittfeld; H J Grabe; D Janowitz; R Bülow; M Selonke; H Völzke; D Grotegerd; U Dannlowski; V Arolt; N Opel; W Heindel; H Kugel; D Hoehn; M Czisch; B Couvy-Duchesne; M E Rentería; L T Strike; M J Wright; N T Mills; G I de Zubicaray; K L McMahon; S E Medland; N G Martin; N A Gillespie; R Goya-Maldonado; O Gruber; B Krämer; S N Hatton; J Lagopoulos; I B Hickie; T Frodl; A Carballedo; E M Frey; L S van Velzen; B W J H Penninx; M-J van Tol; N J van der Wee; C G Davey; B J Harrison; B Mwangi; B Cao; J C Soares; I M Veer; H Walter; D Schoepf; B Zurowski; C Konrad; E Schramm; C Normann; K Schnell; M D Sacchet; I H Gotlib; G M MacQueen; B R Godlewska; T Nickson; A M McIntosh; M Papmeyer; H C Whalley; J Hall; J E Sussmann; M Li; M Walter; L Aftanas; I Brack; N A Bokhan; P M Thompson; D J Veltman
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.